Inventor · disambiguated record
Scott Rollins
Also filed as: ROLLINS SCOTT · ROLLINS SCOTT A
17 granted patents·5 pending applications·1,065 citations·filing 1993–2023
96Inventor score
Top patents by PatentIndex Score
22 records- 0196US6355245B1C5-specific antibodies for the treatment of inflammatory diseasesALEXION PHARMA INC·Filed 1995·Granted Mar 12, 2002·465 cites·23 claims
- 0293US6074642AUse of antibodies specific to human complement component C5 for the treatment of glomerulonephritisALEXION PHARMA INC·Filed 1994·Granted Jun 13, 2000·117 cites·5 claims
- 0392US6338820B1Apparatus for performing assays at reaction sitesALEXION PHARMA INC·Filed 1998·Granted Jan 15, 2002·96 cites·52 claims
- 0487US5847082ATerminal complement inhibitor fusion proteinsALEXION PHARMA INC·Filed 1995·Granted Dec 8, 1998·60 cites·4 claims
- 0585US8945565B2Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodiesROLLINS SCOTT·Filed 2010·Granted Feb 3, 2015·8 cites·18 claims
- 0685US5624837ANucleic acid encoding chimeric complement inhibitor proteinsALEXION PHARMA INC·Filed 1995·Granted Apr 29, 1997·62 cites·8 claims
- 0783US9068001B2Anti-P-selectin antibodiesROLLINS SCOTT·Filed 2011·Granted Jun 30, 2015·8 cites·15 claims
- 0881US7833530B2Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodiesSELEXYS PHARMACEUTICALS CORP·Filed 2009·Granted Nov 16, 2010·6 cites·29 claims
- 0981US6916654B1Universal donor cellsUNIV YALE·Filed 2000·Granted Jul 12, 2005·22 cites·13 claims
- 1080US5627264AChimeric complement inhibitor proteinsALEXION PHARMA INC·Filed 1994·Granted May 6, 1997·54 cites·5 claims
- 1178US6100443AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1995·Granted Aug 8, 2000·31 cites·17 claims
- 1270US5871997AMethods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopesALEXION PHARMA INC·Filed 1995·Granted Feb 16, 1999·19 cites·11 claims
- 1370US5705732AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1993·Granted Jan 6, 1998·24 cites·5 claims
- 1461US2024209097A1Treatment regimensNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1554US5853722AUse of C5-specific antibodies for reducing immune and hemostatic dysfunctions during extracorporeal circulationALEXION PHARMA INC·Filed 1995·Granted Dec 29, 1998·73 cites·8 claims
- 1651US5562904ARetroviral transduction of cells using soluble complement inhibitorsALEXION PHARMA INC·Filed 1994·Granted Oct 8, 1996·14 cites·5 claims
- 1747US2011212096A1Anti-p-selectin antibodies and methods of their use and identificationROLLINS SCOTT·Filed 2010·Application pending·0 cites
- 1843US5891645APorcine E-selectinALEXION PHARMA INC·Filed 1994·Granted Apr 6, 1999·5 cites·6 claims
- 1942US2011081666A1Anti-psgl-1 inhibitors and screening methodsALVAREZ RICHARD·Filed 2010·Application pending·0 cites
- 2041US2020055942A1Treatment regimensNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2137US6040428APorcine E-selectinALEXION PHARMA INC·Filed 1999·Granted Mar 21, 2000·1 cites·3 claims
- 2229US2002045247A1Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitopeFiled 1995·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Rollins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →